Tidal Investments LLC lowered its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 15.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,118 shares of the company's stock after selling 3,964 shares during the quarter. Tidal Investments LLC's holdings in HCA Healthcare were worth $8,989,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC grew its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after purchasing an additional 71 shares during the period. Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $33,000. Finally, Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the 3rd quarter valued at $39,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.
HCA Healthcare Price Performance
HCA traded up $2.87 on Friday, reaching $314.20. The stock had a trading volume of 843,510 shares, compared to its average volume of 1,201,857. The company has a market capitalization of $79.59 billion, a price-to-earnings ratio of 14.01, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a 50-day moving average of $356.94 and a 200-day moving average of $358.27. HCA Healthcare, Inc. has a fifty-two week low of $263.22 and a fifty-two week high of $417.14.
HCA Healthcare Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.84%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is currently 11.85%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Cantor Fitzgerald reissued an "overweight" rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Wells Fargo & Company downgraded shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and decreased their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Barclays decreased their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating on the stock in a research report on Friday, November 8th. Finally, TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $387.13.
Check Out Our Latest Report on HCA Healthcare
Insider Transactions at HCA Healthcare
In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company's stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company's stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
